Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,97%
1.097,32
+21,19
+1,97%
—1.076,131.079,891.100,771.079,89——
SIXC
Communications
SIXC
Communications
SIXC
-0,71%
602,42
-4,32
-0,71%
—606,74606,74607,90602,03——
SIXE
Energy
SIXE
Energy
SIXE
+0,26%
1.252,05
+3,23
+0,26%
—1.248,821.246,371.255,871.239,08——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,99%
1.741,47
+17,11
+0,99%
—1.724,361.733,021.745,751.727,76——
SIXM
Financials
SIXM
Financials
SIXM
-0,10%
634,94
-0,65
-0,10%
—635,59635,08637,89633,31——
SIXR
Staples
SIXR
Staples
SIXR
+0,61%
848,27
+5,12
+0,61%
—843,15842,50848,63840,85——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,18%
216,68
+0,39
+0,18%
—216,29216,29216,91215,24——
SIXT
Technology
SIXT
Technology
SIXT
+2,35%
3.340,16
+77,03
+2,35%
—3.263,413.296,253.342,973.295,42——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,94%
948,10
+8,86
+0,94%
—939,24941,57948,11939,87——
SIXV
Health care
SIXV
Health care
SIXV
+0,31%
1.467,13
+4,57
+0,31%
—1.462,561.465,031.471,261.459,66——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,52%
2.392,78
+12,38
+0,52%
—2.380,402.394,922.412,132.386,94——
Q1 2026 earnings • released • EPS miss -16,86% • Revenue beat +1,93%
See results
BMRN:NASDAQ
Biomarin Pharmaceutical Inc
US$53,36
-3,80%
(-2,10) 1D
5 ພ.ພ., 13 ໂມງ 56 ນາທີ 18 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BMRN...
Open
US$55,57
High
US$57,44
Low
US$53,11
Mkt. cap
໑໐,໓໑ ຕື້
Avg. vol.
໑,໖໐ ລ້ານ
Volume
໑,໖໖ ລ້ານ
P/E ratio
໓໙,໒໐
52-wk high
US$66,28
52-wk low
US$50,76
EPS
US$1,36
Beta
໐,໒໓
Shares outstanding
໑໙໒,໓໒ ລ້ານ
No. of employees
໓ ພັນ
News stories
From sources across the web
Zacks Investment Research
Zacks Investment Research
·
1 ຊົ່ວໂມງກ່ອນ
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised
marketscreener.com
marketscreener.com
·
1 ຊົ່ວໂມງກ່ອນ
BioMarin Pharmaceutical Q1 Revenue Beat Backed by Voxzogo Strength, Diversified Portfolio, Wedbush Says
Investing.com
Investing.com
·
6 ຊົ່ວໂມງກ່ອນ
Bernstein SocGen lowers BioMarin stock price target on guidance update
StockStory
StockStory
·
10 ຊົ່ວໂມງກ່ອນ
BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook
Profile
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
About Biomarin Pharmaceutical Inc
CEOAlexander Hardy
Employees3,22 ພັນ
Foundedມ.ນ. 1997
HeadquartersSan Rafael, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitebiomarin.com
Last report
4 ພ.ພ. 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
໐,໗໖/ (໐,໙໑ est.)USD
-16,86%miss
Revenue / Estimate
໗໖໖,໒໑ ລ້ານ/ (໗໕໑,໖໘ ລ້ານ est.)USD
+1,93%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມ.ນ. 2025
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
Revenue
745,14 ລ້ານ
825,41 ລ້ານ
776,13 ລ້ານ
874,56 ລ້ານ
Cost of goods sold
310,29 ລ້ານ
311,40 ລ້ານ
549,56 ລ້ານ
348,91 ລ້ານ
Cost of revenue
310,29 ລ້ານ
311,40 ລ້ານ
549,56 ລ້ານ
348,91 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
206,12 ລ້ານ
232,28 ລ້ານ
268,42 ລ້ານ
324,16 ລ້ານ
Operating expense
210,96 ລ້ານ
237,12 ລ້ານ
273,26 ລ້ານ
329,01 ລ້ານ
Total operating expenses
521,25 ລ້ານ
548,52 ລ້ານ
822,82 ລ້ານ
677,92 ລ້ານ
Operating income
223,89 ລ້ານ
276,89 ລ້ານ
-46,69 ລ້ານ
196,64 ລ້ານ
Other non operating income
-1,95 ລ້ານ
4,83 ລ້ານ
5,09 ລ້ານ
1,02 ລ້ານ
EBT including unusual items
238,09 ລ້ານ
297,87 ລ້ານ
-26,32 ລ້ານ
-27,15 ລ້ານ
EBT excluding unusual items
238,09 ລ້ານ
297,87 ລ້ານ
-26,32 ລ້ານ
214,10 ລ້ານ
Income tax expense
52,40 ລ້ານ
57,34 ລ້ານ
4,42 ລ້ານ
19,42 ລ້ານ
Effective tax rate
22,01%
19,25%
-16,79%
-71,52%
Other operating expenses
-
-
-
-
Net income
185,69 ລ້ານ
240,53 ລ້ານ
-30,74 ລ້ານ
-46,57 ລ້ານ
Net profit margin
24,92%
29,14%
-3,96%
-5,33%
Earnings per share
1,13
1,44
0,12
0,46
Interest and investment income
19,01 ລ້ານ
18,83 ລ້ານ
17,85 ລ້ານ
19,21 ລ້ານ
Interest expense
-2,86 ລ້ານ
-2,68 ລ້ານ
-2,58 ລ້ານ
-2,78 ລ້ານ
Net interest expenses
16,15 ລ້ານ
16,15 ລ້ານ
15,28 ລ້ານ
16,43 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
245,96 ລ້ານ
295,45 ລ້ານ
-28,20 ລ້ານ
209,68 ລ້ານ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer